CD8+ T cells from patients with SLE have been shown to have an enhanced ability to kill target cells in vitro [30] as well as increased IFN-γ intracellular expression in response to PMA or CD28 stimulation [99,100]. Here, CD8A is linked to systemic lupus erythematosus.